T45.AX2A
ICD-10-CMPoisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter
This code signifies a patient presenting with adverse effects or toxicity resulting from the deliberate self-administration of immune checkpoint inhibitors or other immunostimulant medications. The intent behind the ingestion or administration of these drugs was to cause self-harm. This code is used for the initial phase of treatment for such an event.
Apply this code when a patient is admitted or first seen for an overdose or toxic reaction to an immune checkpoint inhibitor (e.g., pembrolizumab, nivolumab) or an immunostimulant drug, and medical documentation clearly indicates the act was intentional self-harm. This includes emergency department visits, initial hospitalizations, or the first outpatient encounter for this specific poisoning event.
AI-generated reference — verify against official guidelines
+5 more in this category